Abstract
Thiazolidines (TZDs) or glitazones are one of the important classes of insulin sensitizers used in the management of type 2 diabetes mellitus. These agents, however, suffer from some serious side effects such as fluid retention, weight gain, congestive heart failure, bone fracture and possibly bladder cancer, which resulted in their withdrawal from clinical use. The TZDs that were withdrawn from the clinical use were developed at the time when enough scientific data were not available on the structure and the transcriptional mechanisms of peroxisome proliferator activated receptors (PPARs). Recent advances in understanding the structure and function of PPARs, however, has led to more rationalized approaches to develop these agents. The present review discusses the various approaches that have been made to develop newer glitazones devoid of the problems associated with current TZDs. These approaches are based on the structural considerations of both the ligands and the receptors and also on the profile alterations of the ligands.
Keywords: Glitazones, insulin sensitizers, peroxisome proliferator activated receptors, thiazolidinediones, type 2 diabetes mellitus
Mini-Reviews in Organic Chemistry
Title:Newer Approaches to the Discovery of Glitazones
Volume: 10 Issue: 1
Author(s): Praveen Thaggikuppe Krishnamurthy, Moola Joghee Nanjan Chandrasekar and Moola Joghee Nanjan
Affiliation:
Keywords: Glitazones, insulin sensitizers, peroxisome proliferator activated receptors, thiazolidinediones, type 2 diabetes mellitus
Abstract: Thiazolidines (TZDs) or glitazones are one of the important classes of insulin sensitizers used in the management of type 2 diabetes mellitus. These agents, however, suffer from some serious side effects such as fluid retention, weight gain, congestive heart failure, bone fracture and possibly bladder cancer, which resulted in their withdrawal from clinical use. The TZDs that were withdrawn from the clinical use were developed at the time when enough scientific data were not available on the structure and the transcriptional mechanisms of peroxisome proliferator activated receptors (PPARs). Recent advances in understanding the structure and function of PPARs, however, has led to more rationalized approaches to develop these agents. The present review discusses the various approaches that have been made to develop newer glitazones devoid of the problems associated with current TZDs. These approaches are based on the structural considerations of both the ligands and the receptors and also on the profile alterations of the ligands.
Export Options
About this article
Cite this article as:
Thaggikuppe Krishnamurthy Praveen, Joghee Nanjan Chandrasekar Moola and Joghee Nanjan Moola, Newer Approaches to the Discovery of Glitazones, Mini-Reviews in Organic Chemistry 2013; 10 (1) . https://dx.doi.org/10.2174/1570193X11310010005
DOI https://dx.doi.org/10.2174/1570193X11310010005 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
Call for Papers in Thematic Issues
Applications of Molecular Descriptors in Physicochemical Properties Research of Organic Compounds
Chemical graph theory is concerned with all aspects of the application of graph theory to various areas of chemistry, including organic, theoretical, mathematical, and computational chemistry, as well as in bioinformatics and computational biology. By the use of the term chemical it is emphasized that one is allowed in chemical ...read more
Navigating the 2D Universe in Organic Chemistry
This special issue explores the transformative impact of two-dimensional (2D) materials on the realm of organic chemistry, unraveling new possibilities for synthesis, functionalization, and applications of organic compounds. Focused on the unique chemistry within this novel dimension, the issue highlights breakthroughs in the field of 2D organic chemistry. Contributions are ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Overview of Cantharidin and its Analogues
Current Medicinal Chemistry Nucleic Acid Carrier Systems Based on Polyethylenimine Conjugates for the Treatment of Metastatic Tumors
Current Medicinal Chemistry Bladder Cancer: A Simple Model Becomes Complex
Current Genomics MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer
Recent Patents on Biomarkers Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer
Current Cancer Drug Targets Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview
Anti-Cancer Agents in Medicinal Chemistry PET Imaging of Multidrug Resistance in Tumors Using 18F-Fluoropaclitaxel
Current Topics in Medicinal Chemistry Leucine-zipper and Sterile-α Motif Kinase (ZAK): A Potential Target for Drug Discovery
Current Medicinal Chemistry New Cathepsin D Inhibitor Library Utilizing Hydroxyethyl Isosteres with Cyclic Tertiary Amines
Medicinal Chemistry Target Identification of Grape Seed Extract in Colorectal Cancer Using Drug Affinity Responsive Target Stability (DARTS) Technique: Role of Endoplasmic Reticulum Stress Response Proteins
Current Cancer Drug Targets The Macrophage Stimulating Protein/Ron Pathway as a Potential Therapeutic Target to Impede Multiple Mechanisms Involved in Breast Cancer Progression
Current Drug Targets Targeted Enzyme Prodrug Therapies
Mini-Reviews in Medicinal Chemistry DNA Vaccines for Prostate Cancer
Current Cancer Therapy Reviews Delta Np63 alpha – Responsive microRNA Modulate the Expression of Metabolic Enzymes
Current Pharmaceutical Biotechnology The Impact of Combination Therapy with a-Blockers and 5ARIs on the Progression of BPH
Current Drug Targets Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets ATP-Binding Cassette Efflux Transporters in Human Placenta
Current Pharmaceutical Biotechnology Validated RP-HPLC Method for the Simultaneous Analysis of Gemcitabine and LY-364947 in Liposomal Formulations
Current Drug Targets Drug Resistance and Apoptosis in Cancer Treatment: Development of New Apoptosis-Inducing Agents Active in Drug Resistant Malignancies
Current Medicinal Chemistry - Anti-Cancer Agents The Effect of PDE5 Inhibitors on the Male Reproductive Tract
Current Pharmaceutical Design